IMPACT BIOMEDICAL INC (IBO)
AMEXHealth CareBiotechnologySnapshot 2026-09-04
$0.54+12.50%
Close 2026-09-04 · 1-day change
AMEXHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · IBO
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenues | — | 0.0 | — | — | 0.1 | — |
| Cost of Revenues | — | 0.4 | — | — | — | — |
| Operating Expenses & Income | ||||||
| Selling, General & Admin | 2.2 | 0.9 | 0.7 | 0.3 | 0.3 | — |
| R&D Expenses | 0.3 | 0.3 | 0.3 | 1.7 | 1.2 | — |
| Operating Income | (5.1) | (4.3) | (28.8) | (4.0) | (3.4) | — |
| Earnings from Continuing Operations | ||||||
| Interest Expense | — | 0.8 | 1.1 | 0.4 | 0.5 | — |
| Interest & Investment Income | — | — | — | 0.0 | 0.0 | — |
| Net Interest Expenses | — | — | — | 0.4 | 0.4 | — |
| Asset Writedown | — | — | — | — | 4.1 | — |
| EBT, Incl. Unusual Items | (1.8) | (14.5) | (24.7) | (4.4) | (7.9) | — |
| Income Tax Expense | — | (2.6) | 0.0 | — | (0.6) | — |
| Net Income | ||||||
| Minority Interest | (0.0) | (0.0) | (0.1) | (0.1) | — | — |
| Net Income | 0.8 | (11.8) | (24.7) | (4.3) | (7.3) | — |
| Per Share | ||||||
| Basic EPS | 0.01 | (0.38) | (2.30) | (0.07) | (0.10) | — |
| Diluted EPS | — | (0.38) | (2.30) | (0.07) | (0.10) | — |
| Basic Weighted Avg Shares | 107.8 | 31.6 | 10.8 | 60.2 | 70.5 | — |
| Supplemental | ||||||
| EBITDA | — | (3.1) | (27.6) | (2.9) | (2.3) | — |
| EBIT | (5.1) | (4.3) | (28.8) | (4.0) | (3.4) | — |
| Effective Tax Rate | — | — | — | — | 7.9% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.